Immunotherapy Vaccine and Herceptin in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breastcancer
Interventions: DRUG: GP2 peptide + GM-CSF vaccine plus trastuzumab|DRUG: Trastuzumab
Sponsor: Cancer Insight, LLC